Since therapeutic effects of CXCR2 inhibition may also be explained by its direct action on tumor cells (158–160), future studies are needed to determine the contribution of neutrophils to CXCR2 inhibition-related therapeutic effects. This evidence concerns the gene CXCR2 and neoplasm.